Holen Sie sich die Stockscreener-App
82.47
0.40%
0.435
Schlusskurs vom Vortag:
$82.03
Offen:
$82.96
24-Stunden-Volumen:
369.42K
Relative Volume:
0.38
Marktkapitalisierung:
$6.97B
Einnahmen:
$1.31B
Nettoeinkommen (Verlust:
$215.20M
KGV:
33.49
EPS:
2.4627
Netto-Cashflow:
$408.32M
1W Leistung:
-0.11%
1M Leistung:
-1.22%
6M Leistung:
-12.92%
1J Leistung:
-6.36%
1-Tages-Spanne:
$81.12
$82.99
1-Wochen-Bereich:
$79.36
$85.30
52-Wochen-Spanne:
$72.76
$116.65
Healthequity Inc Stock (HQY) Company Profile
Firmenname
Healthequity Inc
Sektor
Branche
Telefon
801-727-1000
Adresse
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, BTSG, TEM, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HQY
Healthequity Inc
|
82.47 | 6.86B | 1.31B | 215.20M | 408.32M | 2.4627 |
VEEV
Veeva Systems Inc
|
173.10 | 25.89B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
53.38 | 9.17B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
54.94 | 9.17B | 1.27B | -245.03M | -245.36M | -1.4071 |
DOCS
Doximity Inc
|
25.02 | 4.54B | 637.78M | 239.40M | 307.21M | 1.1909 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2026-01-09 | Herabstufung | Goldman | Neutral → Sell |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-05-22 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-03-25 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-04-02 | Bestätigt | JP Morgan | Overweight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-10-21 | Hochstufung | Goldman | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-12 | Eingeleitet | Goldman | Sell |
| 2022-04-11 | Eingeleitet | Wells Fargo | Overweight |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-03-30 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-12-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-09-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-07-02 | Eingeleitet | Stephens | Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-01-07 | Eingeleitet | BTIG Research | Neutral |
| 2020-12-08 | Bestätigt | Barrington Research | Outperform |
| 2020-12-02 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-14 | Eingeleitet | Guggenheim | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-03-17 | Bestätigt | Barrington Research | Outperform |
| 2019-10-07 | Eingeleitet | Goldman | Neutral |
| 2019-09-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-07-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-06-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-03-01 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-07 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-12-06 | Herabstufung | SunTrust | Buy → Hold |
| 2018-09-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-05-23 | Eingeleitet | BofA/Merrill | Buy |
| 2018-04-24 | Fortgesetzt | JP Morgan | Overweight |
| 2018-03-20 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-06 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
Healthequity Inc Aktie (HQY) Neueste Nachrichten
Vanguard (NASDAQ: HQY) reports 4.48M HealthEquity shares, 5.3% stake - Stock Titan
HealthEquity, Inc. (NASDAQ:HQY) Short Interest Update - MarketBeat
Vanguard Portfolio Management (HQY) holds 4.24M shares, 5.01% stake - Stock Titan
Assessing HealthEquity (HQY) Valuation After Recent Share Price Move And Mixed Growth Signals - Sahm
HealthEquity gains as BMO upgrades on long-term growth outlook - MSN
HealthEquity, Inc. (HQY) Stock Report: Analyst Ratings Point To 36.9% Upside Potential - DirectorsTalk Interviews
HealthEquity expects FY 2027 revenue between $1.38B and $1.41B; shares down over 7% - MSN
HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
HealthEquity Inc (HQY) Shares Surge 6.0% -- What GF Score of 94 Tells Investors - GuruFocus
Why HealthEquity’s Stock Is Suddenly Rebounding - TipRanks
B. Metzler seel. Sohn & Co. AG Increases Stock Position in HealthEquity, Inc. $HQY - MarketBeat
A Look at HealthEquity Inc (HQY) After 6.2% Decline -- GF Value $100.63 vs Price $77.75 - GuruFocus
Why is HealthEquity (HQY) up 5.2% since last earnings report? - MSN
HQY HealthEquity Inc. delivers Q1 2026 EPS above analyst estimates, shares rise nearly two percent on positive investor sentiment.Neutral Rating - UBND thành phố Hải Phòng
2026 Health Equity Innovation Awards winners announcedWIVT - WIVT - News 34
HealthEquity (HQY) Faces Competition from UnitedHealth's New Acq - GuruFocus
Why (HQY) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Univera names Health Equity Innovation award winners - Audacy
HealthEquity, Inc. (HQY) Investor Outlook: 31% Upside Potential Drives Strong Buy Ratings - DirectorsTalk Interviews
Bayer’s Health Equity Moves And What They Mean For Investors - Yahoo Finance
Massachusetts Financial Services Co. MA Sells 166,205 Shares of HealthEquity, Inc. $HQY - MarketBeat
Will HealthEquity’s (HQY) CTO Exit and Tech Consolidation Reframe Its Digital Transformation Narrative? - simplywall.st
The Cigna Group Foundation Invites Hartford-Area Nonprofits to Apply for $250,000 Health Equity Grants - The Cigna Group Newsroom
Here's Why HealthEquity (HQY) is a Strong Growth Stock - Yahoo Finance
HealthEquity: This Financial Powerhouse Is Poised To Compound Wealth (Upgrade) (HQY) - Seeking Alpha
S&P 500 Futures Up in Premarket Trading; IES Holdings, HealthEquity Lag - Barron's
One company’s million-dollar gambit to turn the healthcare crisis into a gold mine - Popular Information | Judd Legum
HQY SEC FilingsHealthequity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
HealthEquity, Inc. (NASDAQ:HQY) Q1 2026 Earnings Call Transcript - MSN
What metrics matter for HealthEquity (HQY) Stock valuation | Price at $78.37, Up 0.53%Micro Trends - Cổng thông tin điện tử Tỉnh Sơn La
Healthequity's Earnings Surge Can't Outrun Bearish Signals - Bitget
Assessing HealthEquity (HQY) Valuation After CTO Termination And Technology Leadership Transition - Sahm
Retail Trends: Will HealthEquity Inc benefit from AI trendsChart Signals & Advanced Technical Analysis Signals - baoquankhu1.vn
HealthEquity (NASDAQ:HQY) Upgraded to Buy at Wall Street Zen - MarketBeat
Reasons to hold HealthEquity stock in your portfolio for now - MSN
HealthEquity, Inc. (NASDAQ:HQY) Q4 2026 earnings call transcript - MSN
HealthEquity Inc (HQY) Stock Down 7.4% -- Now Undervalued? GF Sc - GuruFocus
HealthEquity Inc (HQY) Stock Down 7.4% -- Now Undervalued? GF Score: 93/100 - GuruFocus
HealthEquity (NASDAQ:HQY) Shares Down 5.5%Here's What Happened - MarketBeat
Understanding Momentum Shifts in (HQY) - Stock Traders Daily
Texas Instruments To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday - Sahm
BMO Capital upgrades HealthEquity (HQY) - MSN
Earnings Update: Does HealthEquity Inc stock reflect fundamentals2026 Selloffs & Weekly High Return Opportunities - baoquankhu1.vn
Finanzdaten der Healthequity Inc-Aktie (HQY)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.19%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):